Effects of large dose of dexamethasone on inflammatory mediators and pancreatic cell apoptosis of rats with severe acute pancreatitis

World J Gastroenterol. 2007 Nov 7;13(41):5506-11. doi: 10.3748/wjg.v13.i41.5506.

Abstract

Aim: To investigate the influence of high dose of dexamethasone on inflammatory mediators and apoptosis of rats with severe acute pancreatitis (SAP).

Methods: SAP rats were randomly assigned to the model group and treatment group while the normal rats were assigned to the sham operation group. The mortality, ascite volumes, ascites/body weight ratio and pancreas pathological changes of all rats were observed at 3, 6 and 12 h after operation. Their contents of amylase and endotoxin in plasma and contents of tumor necrosis factor (TNF-alpha), phospholipase A(2) (PLA(2)) and IL-6 in serum were also determined. The microarray sections of their pancreatic tissues were prepared, terminal transferase dUTP nick end labeling (TUNEL) staining was performed and apoptotic indexes were calculated.

Results: There was no marked difference between treatment group and model group in survival. The contents of amylase and endotoxin in plasma and contents of TNF-alpha, PLA(2) and IL-6 in serum, ascite volumes, ascites/body weight ratio and pancreas pathological scores were all lower in treatment group than in model group to different extents at different time points [P < 0.05, 58.3 (26.4) ng/L vs 77.535 (42.157) ng/L in TNF-alpha content, 8.00 (2.00) points vs 9.00 (2.00) points in pathological score of pancreas respectively; P < 0.01, 0.042 (0.018) EU/mL vs 0.056 (0.0195) EU/mL in endotoxin content, 7791 (1863) U/L vs 9195 (1298) U/L in plasma amylase content, 1.53 (0.79) vs 2.38 (1.10) in ascites/body weight ratio, 8.00 (1.00) points vs 11.00 (1.50) points in pathological score of pancreas; P < 0.001, 3.36 (1.56) ng/L vs 5.65 (1.08) ng/L in IL-6 content, 4.50 (2.00) vs 7.20 (2.00), 4.20 (1.60) vs 6.40 (2.30), 3.40 (2.70) vs 7.90 (1.70) in ascite volumes, respectively]. The apoptotic indexes of pancreas head and pancreas tail were all higher in treatment group than in model group at 6 h [P < 0.01, 0.00 (2.00)% vs 0.00 (0.00)%, 0.20 (1.80) vs 0.00 (0.00) in apoptosis indexes, respectively].

Conclusion: The mechanism of dexamethasone treatment in acute pancreatitis is related to its inhibition of inflammatory mediator generation and induction of pancreatic acinar cell apoptosis.

MeSH terms

  • Acute Disease
  • Amylases / blood
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Apoptosis / drug effects*
  • Ascites / pathology
  • Ascites / prevention & control
  • Body Weight / drug effects
  • Dexamethasone / pharmacology*
  • Dexamethasone / therapeutic use
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endotoxins / blood
  • Inflammation Mediators / blood*
  • Interleukin-6 / blood
  • Male
  • Pancreas / drug effects*
  • Pancreas / enzymology
  • Pancreas / metabolism
  • Pancreas / pathology
  • Pancreatitis / blood
  • Pancreatitis / enzymology
  • Pancreatitis / pathology
  • Pancreatitis / prevention & control*
  • Phospholipases A2 / blood
  • Rats
  • Rats, Sprague-Dawley
  • Severity of Illness Index
  • Time Factors
  • Tissue Array Analysis
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Inflammatory Agents
  • Endotoxins
  • Inflammation Mediators
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Dexamethasone
  • Phospholipases A2
  • Amylases